focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSCIN.L Regulatory News (SCIN)

  • There is currently no data for SCIN

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Bondholder Instruction Fee Deadline Extension

26 Jul 2022 08:00

RNS Number : 6889T
Scottish Investment Trust PLC
26 July 2022
 

To: RNS

From: The Scottish Investment Trust PLC

LEI: 549300ZL6XSHQ48U8H53

Date: 26 July 2022

 

FOR DISTRIBUTION ONLY OUTSIDE THE UNITED STATES TO PERSONS OTHER THAN U.S. PERSONS (AS DEFINED IN REGULATION S UNDER THE UNITED STATES SECURITIES ACT OF 1933, AS AMENDED). NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN OR INTO THE UNITED STATES, CANADA, AUSTRALIA, JAPAN OR THE REPUBLIC OF SOUTH AFRICA OR ANY JURISDICTION FOR WHICH THE SAME COULD BE UNLAWFUL. THE INFORMATION CONTAINED HEREIN DOES NOT CONSTITUTE AN OFFER OF SECURITIES FOR SALE IN ANY JURISDICTION, INCLUDING IN THE UNITED STATES, CANADA, AUSTRALIA, JAPAN OR THE REPUBLIC OF SOUTH AFRICA.

The Scottish Investment Trust PLC

("SIT" or the "Company")

Extension of Bondholder Instruction Fee Deadline and Increase of Instruction Fee

in respect of its outstanding 5 ¾ per cent. secured bonds due 2030 (of which £82,827,000 remains outstanding) (ISIN: GB0002616471 / XS0109354075)

(the "Bonds")

 

In accordance with the terms of the consent solicitation memorandum published by the Company in relation to the Bonds on 30 June 2022 (the "Consent Solicitation Memorandum"), the Board of the Company today announces certain minor changes to the terms of the Consent Solicitation intended to afford all Bondholders the opportunity to fully participate. Capitalised terms used but not defined in this announcement have the same meaning ascribed to them in the Consent Solicitation Memorandum.

In particular, the Board announces (i) the extension of the Instruction Fee Deadline to 4.00 p.m. on 26 July 2022 (the "Extended Instruction Fee Deadline") and (ii) the increase of the Instruction Fee from 0.10 per cent. to 0.20 per cent. of the outstanding principal amount of the Bonds held by the relevant Bondholder and which are the subject of the relevant Electronic Voting Instruction or Ineligible Bondholder Instruction (the "Revised Instruction Fee"). For the avoidance of doubt, the Consent Solicitation, including the terms of the Extraordinary Resolution and the other aspects of the expected timetable set out in the Consent Solicitation Memorandum, remains otherwise unchanged.

Practical Implications

The Extended Instruction Fee Deadline is now the latest time and date for receipt of valid Electronic Voting Instructions or Ineligible Bondholder Instructions by the Tabulation Agent through the Clearing Systems for Bondholders to be eligible for the Revised Instruction Fee. For the avoidance of doubt, those Bondholders who have already submitted valid Electronic Voting Instructions or Ineligible Bondholder Instructions prior to the original Instruction Fee Deadline of 19 July 2022, do not need to submit fresh voting instructions in order to qualify for the Revised Instruction Fee (should it be payable under the terms of the Consent Solicitation Memorandum).

Subject to the terms and conditions set out in the Consent Solicitation Memorandum, SIT will pay to each Bondholder who has delivered a valid Electronic Voting Instruction or Ineligible Bondholder Instruction in respect of the Extraordinary Resolution which has been received by the Tabulation Agent at or prior to the Extended Instruction Fee Deadline, which has not been validly withdrawn at or prior to the Expiration Deadline and which remains in full force and effect until the conclusion of the Meeting, the Revised Instruction Fee. The Company's obligation to pay the Revised Instruction Fee is conditional on, amongst other things, the Extraordinary Resolution being passed by Eligible Bondholders.

Further Information

Any persons with questions regarding the terms of the Proposals or the Consent Solicitation should contact Centrus Financial Advisors Limited ("Centrus") at the addresses or telephone number specified below:

 

Centrus Financial Advisors Limited

85 Queen Victoria Street

London EC4V 4AB

Telephone: +44 (0)20 3846 5676

Attention: Robert St John

Email: robert.stjohn@centrusadvisors.com

 

Centrus is not acting through a U.S. broker-dealer affiliate and, accordingly, will not discuss the Consent Solicitation or the contents of the Consent Solicitation Memorandum or the Notice of Meeting with any Bondholder who is unable to confirm that it is not located or resident in the United States.

The Consent Solicitation Memorandum, the Notice of Meeting and the Substitution Documents contain important information which Bondholders should read carefully before any decision is made with respect to the Consent Solicitation. Bondholders may obtain copies of the Consent Solicitation Memorandum, the Notice of Meeting, the Substitution Documents and any announcements in connection with the Consent Solicitation from the Tabulation Agent:

Tabulation Agent

Kroll Issuer Services Limited

The Shard

32 London Bridge Street

London SE1 9SG

Telephone: +44 (0) 20 7704 0880

Attention: Owen Morris

Email: sitplc@kroll.com 

Website: https://deals.is.kroll.com/sitplc

 

 

Important Information

Within the United Kingdom, this announcement is directed only at persons having professional experience in matters relating to investments who fall within the definition of "investment professionals" in Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 ("relevant persons"). The investment or investment activity to which this announcement relates is only available to and will only be engaged in with relevant persons and persons who receive this announcement who are not relevant persons should not rely or act upon it.

None of the Company, JGGI, Centrus, the Tabulation Agent, the Trustee or any of their respective directors, employees or affiliates makes any representation or recommendation whatsoever regarding the Consent Solicitation, or any recommendation as to whether Bondholders should provide their consent in the Consent Solicitation. This announcement must be read in conjunction with the Consent Solicitation Memorandum. This announcement and the Consent Solicitation Memorandum contain important information which should be read carefully before any decision is made with respect to the Consent Solicitation.

If Bondholders are in any doubt about the action they should take or the contents of this announcement, the Consent Solicitation Memorandum or the Substitution Documents they are recommended to seek their own independent financial advice immediately from their stockbroker, bank manager, solicitor, accountant or other appropriate independent financial adviser who is authorised under the Financial Services and Markets Act 2000 (as amended) if they are in the United Kingdom, or from another appropriately authorised independent financial adviser if they are in a territory outside the United Kingdom. Any person whose Bonds are held on their behalf by a broker, dealer, bank, custodian, trust company or other nominee must contact such entity if it wishes to participate in the Consent Solicitation or otherwise participate in the Meeting (including the adjourned Meeting, if applicable) at which the Extraordinary Resolution is to be considered.

This announcement is not a solicitation of consent with respect to any Bonds and does not constitute an invitation to participate in the Consent Solicitation in or from any jurisdiction in or from which, or to or from any person to or from whom, it is unlawful to make such invitation under applicable securities laws. The Consent Solicitation is being made solely pursuant to the Consent Solicitation Memorandum, which sets forth a detailed statement of the terms of the Consent Solicitation.

The distribution of this announcement in certain jurisdictions may be restricted by law. Persons into whose possession this announcement comes are required to inform themselves about, and to observe, any such restrictions.

The Bonds have not been, and will not be, registered under the U.S. Securities Act of 1933 (the "Securities Act") or the securities law of any state or jurisdiction of the United States and may not be reoffered or resold except pursuant to an applicable exemption from the registration requirements of the Securities Act. Neither the SEC nor any U.S. state securities commission has approved or disapproved of any Bonds, or determined if the Consent Solicitation Memorandum is accurate or complete. Any representation to the contrary is a criminal offence.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCSEUEEIEESEDW
Date   Source Headline
7th Feb 202211:38 amRNSNet Asset Value(s)
4th Feb 202211:14 amRNSNet Asset Value(s)
3rd Feb 202211:08 amRNSNet Asset Value(s)
2nd Feb 202211:25 amRNSNet Asset Value(s)
1st Feb 20224:08 pmRNSResult of AGM
1st Feb 202210:50 amRNSNet Asset Value(s)
31st Jan 202211:28 amRNSNet Asset Value(s)
28th Jan 202210:51 amRNSNet Asset Value(s)
27th Jan 202211:42 amRNSNet Asset Value(s)
26th Jan 202211:08 amRNSNet Asset Value(s)
25th Jan 202211:28 amRNSNet Asset Value(s)
24th Jan 202212:57 pmRNSNet Asset Value(s)
21st Jan 202211:39 amRNSNet Asset Value(s)
21st Jan 20227:00 amRNSAppointment of AIFM
20th Jan 202212:23 pmRNSNet Asset Value(s)
19th Jan 20222:14 pmRNSNet Asset Value(s)
18th Jan 202212:17 pmRNSNet Asset Value(s)
17th Jan 20222:17 pmRNSNet Asset Value(s)
14th Jan 202212:26 pmRNSNet Asset Value(s)
13th Jan 202212:31 pmRNSNet Asset Value(s)
12th Jan 202212:08 pmRNSNet Asset Value(s)
11th Jan 202211:23 amRNSNet Asset Value(s)
10th Jan 20222:51 pmRNSDirector/PDMR Shareholding
10th Jan 202211:55 amRNSNet Asset Value(s)
7th Jan 202212:10 pmRNSNet Asset Value(s)
6th Jan 20221:02 pmRNSNet Asset Value(s)
5th Jan 20222:34 pmRNSDirector/PDMR Shareholding
5th Jan 202212:50 pmRNSNet Asset Value(s)
4th Jan 202211:53 amRNSNet Asset Value(s)
31st Dec 202111:09 amRNSNet Asset Value(s)
30th Dec 202111:21 amRNSNet Asset Value(s)
29th Dec 20211:25 pmRNSNet Asset Value(s)
24th Dec 202112:35 pmRNSNet Asset Value(s)
23rd Dec 20212:49 pmRNSAnnual Financial Report
23rd Dec 202112:07 pmRNSNet Asset Value(s)
22nd Dec 20212:02 pmRNSNet Asset Value(s)
21st Dec 202112:25 pmRNSNet Asset Value(s)
21st Dec 20219:27 amRNSDirector/PDMR Shareholding
20th Dec 20212:14 pmRNSNet Asset Value(s)
20th Dec 20217:01 amRNSDividend Declaration
20th Dec 20217:00 amRNSFinal Results
17th Dec 202111:25 amRNSNet Asset Value(s)
16th Dec 202111:38 amRNSNet Asset Value(s)
15th Dec 202112:54 pmRNSNet Asset Value(s)
14th Dec 202112:32 pmRNSNet Asset Value(s)
13th Dec 202112:48 pmRNSNet Asset Value(s)
13th Dec 20219:24 amRNSDirector/PDMR Shareholding
10th Dec 202111:40 amRNSNet Asset Value(s)
9th Dec 20212:11 pmRNSResult of General Meeting
9th Dec 20211:30 pmRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.